tiprankstipranks
Trending News
More News >
Arrowhead Pharmaceuticals, Inc. (ARWR)
:ARWR
US Market

Arrowhead Pharmaceuticals (ARWR) Income Statement

Compare
1,652 Followers

Arrowhead Pharmaceuticals Income Statement

Last quarter (Q3 2025), Arrowhead Pharmaceuticals's total revenue was $27.77M, an increase of Infinity% from the same quarter last year. In Q3, Arrowhead Pharmaceuticals's net income was $-175.24M. See Arrowhead Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 829.45M$ 3.55M$ 240.74M$ 243.23M$ 138.29M
Gross Profit
$ 0.00$ 3.55M$ 240.74M$ 243.23M$ 138.29M
Operating Expenses
$ 731.10M$ 604.63M$ 445.74M$ 421.74M$ 287.32M
Depreciation and Amortization
$ 0.00$ 18.59M$ 12.49M$ 10.42M$ 8.27M
EBITDA
$ 98.35M$ -561.51M$ -175.67M$ -162.29M$ -132.58M
Operating Income
$ 98.35M$ -601.08M$ -205.00M$ -178.51M$ -149.04M
Other Income/Expenses
$ 0.00$ -11.38M$ -1.49M$ 5.80M$ 8.19M
Pretax Income
$ 19.79M$ -612.46M$ -206.49M$ -172.71M$ -140.85M
Net Income
$ -1.63M$ -599.49M$ -205.28M$ -176.06M$ -140.85M
Per Share Metrics
Basic EPS
$ -0.01$ -5.00$ -1.91$ -1.67$ -1.36
Diluted EPS
$ -0.01$ -5.00$ -1.92$ -1.67$ -1.36
Weighted Average Shares Outstanding
133.76M 119.78M 107.31M 105.43M 103.75M
Weighted Average Shares Outstanding (Diluted)
133.76M 119.78M 106.75M 105.43M 103.75M
Currency in USD

Arrowhead Pharmaceuticals Earnings and Revenue History